Thomas Boulet Selected Research

Thomas Boulet Research Topics

8	Breast Neoplasms (Breast Cancer) 11/2023 - 12/2009
4	Neoplasms (Cancer) 10/2022 - 08/2007
1	Fatigue 01/2020
1	Vomiting 01/2020
1	Nausea 01/2020
1	Breast Diseases (Breast Disease) 01/2020
1	Constipation 01/2020
1	Viremia 03/2011
1	Injection Site Reaction 09/2010
1	Neoplasm Metastasis (Metastasis) 12/2009
1	HIV Infections (HIV Infection) 07/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2008
1	Lung Neoplasms (Lung Cancer) 07/2008

5	Trastuzumab (Herceptin)FDA Link 11/2023 - 01/2019
5	Ado-Trastuzumab EmtansineIBA 10/2022 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 08/2007
3	ErbB Receptors (EGF Receptor)IBA 10/2022 - 01/2019
2	pertuzumabIBA 10/2022 - 01/2019
2	AnthracyclinesIBA 10/2022 - 01/2020
2	taxaneIBA 10/2022 - 01/2020
2	Enfuvirtide (Fuzeon)FDA Link 03/2011 - 09/2010
1	Tumor Biomarkers (Tumor Markers)IBA 11/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	human ERBB2 proteinIBA 10/2022
1	Hormones (Hormone)IBA 10/2022
1	atezolizumabIBA 10/2022
1	Taxoids (Taxanes)IBA 10/2022
1	Epidermal Growth Factor (EGF)IBA 09/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Raltegravir Potassium FDA Link 03/2011
1	IntegrasesIBA 03/2011
1	Integrase InhibitorsIBA 03/2011
1	Chemokine CXCL12IBA 12/2009
1	LigandsIBA 12/2009
1	Interleukin-2 (IL2)IBA 07/2009